Imprinting disorders Flashcards

1
Q

What is the issue with gene imprinting with a pathological view?

A
  • both maternal and paternal copies are present but only one is active
  • no backup copy—a mutation in the active gene can lead to disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When does disease arise in imprinted genes?

A
  • The only functional copy is mutated.
  • Both copies are erroneously silenced, leading to a complete loss of gene function.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Beckwith-Wiedemann Syndrome (BWS) and its symptoms?

A
  • A pediatric overgrowth disorder associated with an increased risk of tumor development.

Symptoms vary but include:
- Macrosomia (large body size)
- Organomegaly (enlarged organs)
- Abdominal wall defects
- By adulthood, growth abnormalities typically normalize.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the genetic basis of BWS?

A
  • Linked to IGF-II (Insulin-like Growth Factor 2), an imprinted gene that is normally only expressed from the paternal allele.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What did the familial study in South Africa show about BWS?

A
  • Showed BWS recurring in the same family tree, unusual for a rare disorder.
  • Mutation originated in the grandfather, who passed on an imprinting defect to his grandchildren.
  • Provided key evidence that BWS is an imprinting disorder rather than a classical Mendelian inheritance pattern.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the key features of Prader-Willi Syndrome (PWS)?

A
  • Obesity
  • Behavioral & cognitive impairments
  • Underdeveloped sexual characteristics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the genetic mechanism of PWS?

A

Loss of paternal gene function in the PW critical region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the key features of Angelman syndrome (AS)?

A
  • severe developmental delays
  • ataxia, epilepsy
  • characteristic “happy” demeanour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the genetic mechanism of AS?

A

Loss of maternal gene function in the AS critical region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main genetic causes of PWS?

A

-70% – Paternal deletion of the Prader-Willi region (15q11-q13).

  • 25% – Uniparental disomy (UPD) (two maternal copies, both silenced).

**This likely results from trisomy rescue, where an extra chromosome was lost, but the remaining pair came from the mother.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the other genetic causes of PWS?

A
  • Mutation in the imprinting control region – No signal to remove imprinting marks, preventing gene activation.
  • Chromosomal translocation – Misplaced regulatory sequences cause incorrect imprinting patterns.

**Can reduce fertility due to improper chromosomal pairing during meiosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main therapeutic goal for PWS treatment?

A

Reactivate the silenced maternal genes since the paternal ones are missing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is CRISPR-based gene activation a strategy for PWS treatment?

A
  • Uses Cas9 modified to activate transcription instead of cutting DNA.
  • Targets the maternal chromosome to remove silencing.
  • Can also alter methylation patterns by recruiting histone-modifying enzymes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does targeting the antisense transcript act as a therapeutic treatment for PWS?

A
  • Some imprinted genes require antisense RNAs to maintain silencing.
  • Downregulating Air RNA could allow genes on the maternal chromosome to be expressed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can topoisomerase inhibitors act as a therapeutic treatment for PWS?

A
  • Can unlock chromatin structure, facilitating gene activation on the maternal chromosome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can gene replacement therapy act as a therapeutic treatment for PWS?

A
  • AAV (Adeno-Associated Virus) vectors deliver functional copies of the missing genes.
17
Q

How can metabolic interventions act as a therapeutic treatment for PWS symptoms?

A
  • Introducing Brain-Derived Neurotrophic Factor (BDNF) into the hypothalamus may help regulate energy balance and appetite.
18
Q

How can ShRNA/AAV9 Therapy
act as a therapeutic treatment for PWS?

A
  • Targets EHMT2, a chromatin remodeler that contributes to gene silencing.

**Concern: EHMT2 has multiple functions, and silencing it may have unintended consequences.

19
Q

What are the key challenges in gene therapy for PWS?

A
  • Different genetic causes require different approaches.
  • Target specificity is crucial to avoid off-target effects.
  • Long-term safety & effectiveness need to be established before clinical use.